Transpososome Complexes for Controlled DNA Fragmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for nucleic acid fragmentation in Next Generation Sequencing (NGS) library preparation are inefficient, requiring large input DNA amounts, multiple steps, and can introduce sequence biases and chimeric sequences, while traditional workflows often necessitate separate steps and large DNA quantities.
Innovation Solution
The use of transpososome complexes comprising transposases and specially designed transposon ends with modified sequences, such as nicks or apurinic sites, for controlled in vitro fragmentation, allowing for efficient generation of nucleic acid fragments with uniform terminal sequences in a single reaction mixture, reducing sequence bias and enabling low-input DNA analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional nucleic acid fragmentation methods are used, then DNA can be fragmented, but large input DNA amounts are required and multiple steps are needed
Solution Approach 1:
The patent combines multiple fragmentation steps into a single transposition reaction. The transpososome complex performs both DNA cleavage and fragment generation in one step, eliminating the need for separate sonication, enzymatic digestion, or mechanical shearing steps required by traditional methods.
Solution Approach 2:
The transposase enzyme serves multiple functions: it acts as both a cleavage enzyme to cut DNA at specific sites and as a fragment generation mechanism through transposition. This multi-functionality reduces the number of reagents and steps needed compared to traditional specialized enzymes for each function.
2Reliability
If traditional fragmentation methods are used, then DNA fragmentation can be achieved, but sequence biases and chimeric sequences are introduced
Solution Approach 1:
The transposon end sequences are specifically designed with controlled modifications (nicks, gaps, apurinic sites) at precise locations to ensure uniform cleavage. This localized precision prevents random fragmentation biases that occur with sonication or mechanical shearing, ensuring uniform terminal sequences across all fragments.
Solution Approach 2:
The patent modifies the transposon end sequence parameters (introducing nicks, gaps, or apurinic sites at specific positions) to control the cleavage behavior of the transposase. These parameter changes ensure that fragmentation occurs at defined locations rather than randomly, eliminating sequence bias while maintaining reproducibility.
3Productivity
If multiple steps are used for DNA fragmentation, then fragmentation can be achieved, but the workflow becomes complex and time-consuming
Solution Approach 1:
The patent merges DNA cleavage, fragment generation, and library preparation steps into a single transposition reaction. The transpososome complex performs all these functions simultaneously, reducing the workflow from multiple sequential steps to one streamlined process.
Solution Approach 2:
The transpososome complexes are pre-assembled with modified transposon end sequences before the reaction. This preliminary preparation ensures that when the transposition reaction occurs, fragmentation and library preparation happen in one step without requiring subsequent processing steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient, low-input DNA fragmentation with reduced sequence bias, allowing for high-quality NGS library preparation, random nucleic acid fragments, and unbiased representation of genomic sequences, suitable for whole-genome analysis and metagenomic studies.
Implementation Method 1
transpososome complexes comprising transposases and specially designed transposon ends with modified sequences
Data Source
AI summary
A composition and method for controlled in vitro fragmentation of nucleic acids. A transposase forms catalytically active complexes with a modified transposon end that contains within its end sequence degenerate, apurinic/apyrimidinic sites, nicks, or nucleotide gaps, to fragment or shear a target nucleic acid sample in a controlled process. This method yields desired average nucleic acid fragment sizes. The inventive composition and method may be applied for generation of DNA fragments containing shortened transposon end sequences to facilitate subsequent reactions, for production of asymmetrically tailed DNA fragments, etc.